共 49 条
Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): Where are we now?
被引:16
作者:
Denecke, Jonas
[1
]
Marquardt, Thorsten
[2
]
机构:
[1] Univ Hosp Rostock, Dept Pediat, D-18057 Rostock, Germany
[2] Univ Hosp Muenster, Dept Pediat, Munster, Germany
来源:
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
|
2009年
/
1792卷
/
09期
关键词:
Hempas;
CDA II;
Congenital disorders of glycosylation;
Dyserythropoiesis;
Erythrocyte membrane glycosylation;
CDAN2;
ERYTHROCYTE-MEMBRANE PROTEINS;
HEREDITARY ERYTHROBLASTIC MULTINUCLEARITY;
N-GLYCANS;
CDA-II;
CLINICAL-APPEARANCE;
MOLECULAR-BASIS;
CELL MEMBRANE;
ANTI-I;
GLYCOSYLATION;
GENE;
D O I:
10.1016/j.bbadis.2008.12.005
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
Congenital diserythropoietic anemias (CDA) were classified according to bone marrow changes and biochemical features 40 years ago. A consistent finding in CDA type II, the most frequent subgroup of CDAs is a relevant hypoglycosylation of erythrocyte membrane proteins. It is a matter of debate if the hypoglycosylation is the primary cause of the disorder or a phenomenon secondary to other pathomechanisms. The molecular cause of the disorder is still unknown although some enzyme deficiencies have been proposed to cause CDA II in the last 2 decades and a linkage analysis locating the CDA 11 gene in a 5 cM region on chromosome 20 was done in 1997. In this review biochemical and genetic data are discussed and diagnostic methods based on biochemical observations of the recent years are reviewed. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 49 条